MISSISSAUGA, ON / ACCESSWIRE / December 3, 2021 / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV:COV)(OTCQX:CVALF), an advanced medical technologies company, today announced that it will be presenting at the SNN Network Canada Virtual Event 2021 on Wednesday, December 8, 2021, at 3:30 PM EST. Brian Pedlar, Chief Executive Officer of Covalon, will be hosting the presentation and answering questions from investors.
To access the live presentation, please use the following information:
SNN Network Canada Virtual Event 2021
Date: Wednesday, December 8, 2021
Time: 3:30 PM Eastern Time
Webcast: https://www.webcaster4.com/Webcast/Page/2813/43826
Covalon is an innovation-driven medical device company, with a strong portfolio of patented dressings and technology that make it easier for health care providers to protect patients from infection and help patients heal. Whether suffering from a chronic wound, recovering from a surgery, or undergoing treatment that requires vascular insertions, patients benefit from Covalon's family of FDA approved products and technology that are designed to reduce complications during treatments.
With the recently completed sale of its AquaGuard product line, Covalon is debt free with over $24 million of cash (approximately $0.93 per share) on its balance sheet. Covalon is positioned extremely well to further accelerate the growth of its biological collagen and antimicrobial products that have been contributing to revenue growth this fiscal year.
If you would like to book 1on1 investor meetings with Covalon, and to watch Covalon's presentation, please make sure you are registered for the virtual event here:
https://canada.snn.network/signup
1on1 meetings will be scheduled and conducted via private, secure video conference through the conference event platform.
The SNN Network Canada Virtual Event website is available here:
If you can't make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Agenda":
https://canada.snn.network/agenda
News Compliments of Accesswire
About Covalon
Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) by developing products that are sold under Covalon's name; and (ii) by developing and commercializing medical products for other medical companies under development and license contracts. The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTQX Market under the symbol CVALF. To learn more about Covalon, visit our website at www.covalon.com.
About SNN.Network
SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU'RE interested in; find out about investor conferences YOU want to attend - all here on SNN Network.
If you would like to attend the SNN Network Summer Virtual Event 2021, please register here:
https://conference.snn.network/signup
Contact:
Name: Brian Pedlar, CEO
Phone: 905.568.8400 x 233
Address: 5-1660 Tech Avenue, Mississauga, ON, Canada, L4W 5S7
Email: [email protected]
Website: www.covalon.com
Twitter: @covalon
SOURCE: Covalon Technologies Ltd. via SNN Network